Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jay Overholser
Phase 1 Immunotherapy Trial With Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Sustained Release of Actives With Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, Two Adjuvants Dedicated to Human Therapeutic Vaccines
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
O3-2-5a Phase I Trial of BI 754091, a Programmed Death Receptor 1 (PD-1) Inhibitor, in Patients With Advanced Solid Tumors
Annals of Oncology
Medicine
Oncology
Hematology
First-In-Human Phase 1 Trial of Agarose Beads Containing Murine RENCA Cells in Advanced Solid Tumors
Cancer Growth and Metastasis
A Phase 1 Study of Oral Ridaforolimus in Pediatric Patients With Advanced Solid Tumors
Oncotarget
Oncology
A Phase I Trial of SJG-136 (NSC#694501) in Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients With Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
Frontiers in Immunology
Allergy
Immunology
Safety and Immunogenicity of Multi-Antigen AMA1-based Vaccines Formulated With CoVaccine HT™ and Montanide ISA 51 in Rhesus Macaques
Malaria Journal
Parasitology
Infectious Diseases
Pharmacodynamics (PD) and Pharmacokinetics (PK) of E7389 (Eribulin, Halichondrin B Analog) During a Phase I Trial in Patients With Advanced Solid Tumors: A California Cancer Consortium Trial
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
